And if we were to get one, which will not happen at least till 2026, then it would be a no brainer for a bigger pharma to run both acne and rosacea phase 3's simultaneously.
Just think if one only is a success.
Makes some recent numbers look pathetic doesnt it.
Now you know what management think when they value themselves so highly.
Food for thought but it won't make you fat. Try roast duck with a nice pinot. Bin Night Romeos tonight with a mate on the big white Gretsch and boy can he play.
Ann: Botanix Appendix 4E & Announcement of Commercial Day Webinar, page-57
-
- There are more pages in this discussion • 51 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add BOT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
37.0¢ |
Change
-0.010(2.63%) |
Mkt cap ! $671.1M | |||
| Open | High | Low | Value | Volume |
| 38.0¢ | 38.0¢ | 37.0¢ | $1.949M | 5.207M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 7 | 163455 | 37.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 37.5¢ | 33207 | 2 |
View Market Depth
| Last trade - 16.10pm 04/10/2024 (20 minute delay) ? |
| BOT (ASX) Chart |